A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–45
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Individuals with Autistic Disorder or Asperger's Syndrome:
Male adults, 18 to 45 years of age inclusive
Diagnosis of Autistic Disorder or Asperger's Syndrome as defined by DSM-IV
IQ \>70
Body mass index (BMI) 18 to 35 kg/m2
Availability of a reliable caregiver, able and willing to provide information regarding the individual's behavior and symptoms
Healthy controls:
Healthy male adults, 18 to 45 years of age inclusive
IQ \>70
Body mass index (BMI) 18 to 30 kg/m2
You may not be if
Positive test for drugs of abuse or alcohol
Confirmed systolic blood pressure \>140 or \<90 mmHg, and diastolic blood pressure \>90 or \<50 mmHg
Resting pulse rate \>100 or \<40 beats per minute
Alcohol and/or substance abuse/dependence during the last 12 months
Concomitant disease or condition that could interfere with, or treatment of which might interfere with, the conduct of the study, or that would, in the opinion of the investigator, pose an unacceptable risk to the subject in this study
Additionally for individuals with Autistic Disorder or Asperger's Syndrome:
History of epilepsy/seizure disorder (except simple febrile seizures)
* Significant disruptive, aggressive or self-injurious, or sexually inappropriate behavior during the last 3 months that in the opinion of the investigator might interfere with the conduct of the study
Additionally for healthy controls:
Clinically significant abnormalities in laboratory test results
History of or current psychiatric, neurological disorder or pervasive developmental disorder
Clareo Health | A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
